A shorter time interval between the first and the second tumor in women affected by MBCs did not predict a worse OS or DFS but resulted to be associated with a significantly lower hormone receptors positivity (P < 0.05) of the second MBC. The gene discussed is NR4A1; the disease is maternal uniparental disomy of chromosome 20.